A Phase I Study of Gemcitabine, Nab-Paclitaxel, and Bosentan in Patients With Unresectable Pancreatic Cancer
The purpose of this phase I trial is to evaluate the safety and feasibility of bosentan in combination with nab-paclitaxel, and gemcitabine in patients with unresectable pancreatic cancer.
Study ID: 21314
Trial Phase: Phase I
Trial Sponsor: City of Hope
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, Bosentan